← Back to Search

Prehabilitation for Pancreatic Cancer

Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH
Targeting 2 different conditionsNutritional +3 moreN/AWaitlist AvailableResearch Sponsored by Case Comprehensive Cancer Center

Study Summary

This trial is looking at a new way to prepare people for surgery to remove pancreatic or periampullary neoplasms.

Eligible Conditions
  • Periampullary Carcinoma
  • Pancreatic Cancer


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks after the surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks after the surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in participants physical capacity, as represented by hand grip strength
Secondary outcome measures
Morbidity rate
Mortality Rate
Physical capacity as represented by 30s CST (Chair Stand Test )
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Arm (Prehabilitation)Experimental Treatment4 Interventions
Participants in the intervention arm will receive all of the standard of care, as listed above, as well as individualized exercise and nutritional prehabilitation regimens. During the data analysis, participants will be subdivided into treatment groups, upfront surgical resection versus neoadjuvant chemotherapy, in order to determine whether length of prehabilitation affected outcomes and distinguish any possible effect of chemotherapy toxicity.
Group II: Control Arm (Standard of Care)Active Control2 Interventions
Participants will receive the current standard preoperative education and counseling. Participants will receive information regarding exercise and nutrition from a member of the surgical team. Participants will meet with a behavioral medicine specialist for additional education regarding factors affecting postoperative stress and relaxation techniques. Participants who are actively smoking will be counseled regarding smoking cessation and offered a referral to smoking cessation resources.
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
442 Previous Clinical Trials
30,781 Total Patients Enrolled

Media Library

Nutritional Clinical Trial Eligibility Overview. Trial Name: NCT05225038 — N/A
Pancreatic Cancer Research Study Groups: Control Arm (Standard of Care), Intervention Arm (Prehabilitation)
Pancreatic Cancer Clinical Trial 2023: Nutritional Highlights & Side Effects. Trial Name: NCT05225038 — N/A
Nutritional 2023 Treatment Timeline for Medical Study. Trial Name: NCT05225038 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research effort currently seeking participants?

"According to clinicaltrials.gov, this medical trial has ceased recruitment since its original post date of June 13th 2022 and most recent update on August 3rd 2022. Nonetheless, there are 2906 other studies currently recruiting patients for participation."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What site did they apply to?
Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~41 spots leftby Dec 2024